Affiliation: | 1. Uehiro Centre for Practical Ethics, Faculty of Philosophy, University of Oxford, Oxford, UK;2. Uehiro Centre for Practical Ethics, Faculty of Philosophy, University of Oxford, Oxford, UK Murdoch Children’s Research Institute, Royal Children’s Hospital, Melbourne, Australia Department of Neonatology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK;3. Nuffield Department of Anaesthetics, Oxford University Hospitals NHS Foundation Trust, Oxford, UK University of Oxford, Oxford, UK |
Abstract: | In this article, we describe an extension of general anaesthesia – beyond facilitating surgery – to the relief of suffering during dying. Some refractory symptoms at the end of life (pain, delirium, distress, dyspnoea) might be managed by analgesia, but in high doses, adverse effects (e.g. respiratory depression) can hasten death. Sedation may be needed for agitation or distress and can be administered as continuous deep sedation (also referred to as terminal or palliative sedation) generally using benzodiazepines. However, for some patients these interventions are not enough, and others may express a clear desire to be completely unconscious as they die. We summarise the historical background of an established practice that we refer to as ‘general anaesthesia in end-of-life care’. We discuss its contexts and some ethical and legal issues that it raises, arguing that these are largely similar issues to those already raised by continuous deep sedation. To be a valid option, general anaesthesia in end-of-life care will require a clear multidisciplinary framework and consensus practice guidelines. We see these as an impending development for which the specialty should prepare. General anaesthesia in end-of-life care raises an important debate about the possible role of anaesthesia in the relief of suffering beyond the context of surgical/diagnostic interventions. |